Predicting the macromolecular targets of drug-like molecules has become everyday practice in medicinal chemistry. We present an overview of our recent research activities in the area of polypharmacology-guided drug design. A focus is put on the self-organizing map (SOM) as a tool for compound clustering and visualization. We show how the SOM can be efficiently used for target-panel prediction, drug re-purposing, and the design of focused compound libraries. We also present the concept of virtual organic synthesis in combination with quantitative estimates of ligand-receptor binding, which we used for de novo designing target-selective ligands. We expect these and related approaches to enable the future discovery of personalized medicines
Background: Drug approval applications to the FDA have shown a remarkably small increment compared w...
Drug repositioning, or the identification of new indications for known drugs, is a useful strategy f...
To improve the discovery of more effective and less toxic pharmaceutical agents, large virtual repos...
Abstract: We present a self-organizing map (SOM) approach to predicting macromolecular targets for c...
We present a self-organizing map (SOM) approach to predicting macromolecular targets for combinatori...
The “one drug – one target – one disease ” paradigm in drug discovery has been reconsidered during t...
Background: Polypharmacology, defined as the modulation of multiple proteins rather than a single ta...
Background: Polypharmacology, defined as the modulation of multiple proteins rather than a single ta...
© 2015 Springer International Publishing Switzerland. Intuitive, visual rendering - mapping - of hig...
Flexibility, structural adaptability and non-selective pharmacophoric features of ligands and macrom...
Design of multitarget drugs and polypharmacological compounds has become popular during the past dec...
Polypharmacology, a new paradigm in drug discovery that focuses on multi-target drugs (MTDs), has po...
Design of multitarget drugs and polypharmacological compounds has become popular during the past dec...
As part of a large medicinal chemistry program, we wish to develop novel selective estrogen receptor...
In recent years, polypharmacology has increasingly gained attention. Pharmaceutical companies have d...
Background: Drug approval applications to the FDA have shown a remarkably small increment compared w...
Drug repositioning, or the identification of new indications for known drugs, is a useful strategy f...
To improve the discovery of more effective and less toxic pharmaceutical agents, large virtual repos...
Abstract: We present a self-organizing map (SOM) approach to predicting macromolecular targets for c...
We present a self-organizing map (SOM) approach to predicting macromolecular targets for combinatori...
The “one drug – one target – one disease ” paradigm in drug discovery has been reconsidered during t...
Background: Polypharmacology, defined as the modulation of multiple proteins rather than a single ta...
Background: Polypharmacology, defined as the modulation of multiple proteins rather than a single ta...
© 2015 Springer International Publishing Switzerland. Intuitive, visual rendering - mapping - of hig...
Flexibility, structural adaptability and non-selective pharmacophoric features of ligands and macrom...
Design of multitarget drugs and polypharmacological compounds has become popular during the past dec...
Polypharmacology, a new paradigm in drug discovery that focuses on multi-target drugs (MTDs), has po...
Design of multitarget drugs and polypharmacological compounds has become popular during the past dec...
As part of a large medicinal chemistry program, we wish to develop novel selective estrogen receptor...
In recent years, polypharmacology has increasingly gained attention. Pharmaceutical companies have d...
Background: Drug approval applications to the FDA have shown a remarkably small increment compared w...
Drug repositioning, or the identification of new indications for known drugs, is a useful strategy f...
To improve the discovery of more effective and less toxic pharmaceutical agents, large virtual repos...